Evaluating the Efficacy of Amniotic Membrane in Treating Neonatal Extravasation
-
Published:2023-06
Issue:6
Volume:36
Page:1-6
-
ISSN:1538-8654
-
Container-title:Advances in Skin & Wound Care
-
language:en
-
Short-container-title:Adv Skin Wound Care
Author:
Kadivar Maliheh,Bitaraf Masoud,Nasrabadi Seyed Ali Hashemi,Mirnia Kayvan
Abstract
ABSTRACT
OBJECTIVE
Extravasation is leakage of material from a peripheral venous access into adjacent tissue, which results in tissue damage ranging from local irritation to necrosis and scar formation. Neonates are at extravasation risk with IV treatment because of their small, fragile veins and the long treatment period required. In this report, investigators assessed the efficacy of amniotic membrane (AM) as a biological dressing to heal extravasation wounds in neonates.
METHODS
This case series includes six neonates who presented with extravasation injuries from February 2020 to April 2022. Neonates born at any gestational age diagnosed with a wound secondary to extravasation were recruited. Neonates with skin disorders and those who had stage 1 or 2 wounds were excluded. Providers covered infection- and necrosis-free wounds with AM and assessed the wounds after 48 hours. Five days after placement, providers removed and replaced the AM; they continued to replace the bandages every 5 to 7 days until healed.
RESULTS
The average gestational age of included neonates was 33.6 weeks. Average healing time was 12.5 days (range, 10-20 days), and no adverse reactions were observed. All neonates healed completely without scar formation.
CONCLUSIONS
This preliminary report suggests that the application of AM in treating extravasation in neonates is safe and effective. However, controlled trials with larger sample sizes are needed to evaluate this outcome and determine implications for practice.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Advanced and Specialized Nursing,Dermatology
Reference37 articles.
1. Neonatal pharmacology: extensive interindividual variability despite limited size;J Pediatr Pharmacol Ther,2011
2. Specific features of pharmacokinetics in children;Drug Metab Rev,2016
3. Neonatal extravasation injury: prevention and management in Australia and New Zealand—a survey of current practice;BMC Pediatr,2013
4. Describing intravenous extravasation in children (DIVE Study);Can J Hosp Pharm,2011
5. Severe extravasation injuries in neonates: a report of 34 cases;Pediatr Dermatol,2015
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献